• Clinical science

Obstructive sleep apnea


Obstructive sleep apnea (OSA) is the most common breathing-related sleep disorder and is typically associated with obesity. It is characterized by obstruction of the upper airways due to the collapse of the pharyngeal muscles. OSA results in multiple episodes of interrupted breathing (apnea and hypopnea) during sleep, which leads to alveolar hypoventilation. Affected individuals generally suffer from severe daytime sleepiness and impaired cognitive function (e.g., deficits in attention and/or memory) as a result of sleep disruption. Their partners commonly describe observing restless sleep associated with irregular snoring, gasping, or choking episodes. Diagnosis is based on the assessment of risk factors and polysomnography. Many patients with OSA (> 50%) are affected by secondary hypertension. The cardiovascular consequences of secondary hypertension reduce life expectancy. However, these effects can be counteracted with weight loss and nightly continuous positive airway pressure (CPAP). Other important aspects of management include avoidance of precipitating factors (e.g., alcohol) and improvement of sleep hygiene.


  • Obstructive sleep apnea (OSA): breathing-related sleep disorder in which airflow significantly decreases or ceases because of upper airway obstruction (typically the oropharynx)
  • Apnea: respiratory arrests of ≥ 10 seconds
  • Hypopnea: reduction of airflow by ≥ 30% of pre-event baseline for ≥ 10 seconds in combination with reduction of blood oxygenation by ≥ 3% or EEG arousal



  • Sex: > (2:1)
  • Prevalence: ∼ 20–30% in men and 10–15% in women


Epidemiological data refers to the US, unless otherwise specified.


Obesity is the most important risk factor for OSA.




Clinical features

  • Restless sleep with waking, gasping, or choking
  • Loud, irregular snoring with apneic episodes (third-party reports)
  • Excessive daytime sleepiness (e.g., patient falls asleep, microsleep during meetings or while watching TV)
  • Impaired cognitive function; (e.g., impaired concentration, memory loss)
  • Depression, decreased libido



General considerations

  • Initial assessment: standardized questionnaires and third-party reports; (interview sleeping partner regarding snoring and respiratory interruptions)
  • Laboratory tests are not usually considered useful in the diagnosis of OSA, but may help identify underlying conditions or physiological consequences of OSA.

Sleep studies

Obstructive sleep apnea is a very frequent cause of secondary hypertension!


Differential diagnoses

Central sleep apnea (CSA)

  • Definition: Breathing-related sleep disorder characterized by repetitive cessation or decrease of respiratory effort during sleep due to impaired function of the respiratory center. Airway obstruction is absent.
  • Etiology: idiopathic or caused by an underlying disorder
  • Risk factors
  • Pathophysiology: lack of stimulation to the respiratory center with patent upper airways → periodic lack of respiratory muscle innervation → interruption of thoracic and/or abdominal respiratory movements
  • Clinical features
    • Morning headaches
    • Repeated waking at night
    • Daytime sleepiness
    • Snoring
    • Association with OSA is very common
    • Possibly Cheyne-Stokes breathing (especially in patients with heart failure)
  • Diagnosis
  • Treatment
    • Treat underlying disorder (if present)
    • CPAP

The 3 C’s of Central sleep apnea are Congestive heart failure, CNS trauma or toxicity, and Cheyne-Stokes breathing.

Obesity hypoventilation syndrome (Pickwickian syndrome)

  • Definition: : a breathing disorder that only affects morbidly obese individuals; ; frequently accompanied by OSA, it is characterized by diurnal hypercapnia
  • Etiology: obesity (BMI ≥ 30 kg/m2)
  • Risk factors: identical to those of obesity
  • Pathophysiology: obesity reduces inspiratory muscle strength and restricts respiratory excursions → alveolar hypoventilation, sleep-disordered breathing (e.g., OSA), and failure of ventilatory compensatory mechanisms → decreased PaO2 and increased PaCO2 during sleep (PaCO2 retention extends to the waking hours)
  • Clinical features
    • Same symptoms as those of OSA
    • Headaches and severe sleepiness
  • Diagnostic criteria
    • BMI ≥ 30 kg/m2
    • Arterial blood gasses showing diurnal hypercapnia (PaCO2 > 45 mm Hg) that cannot not be explained by another condition
    • Polysomnography shows hypoventilation during sleep with or without obstructive apnea events.
  • Treatment


The differential diagnoses listed here are not exhaustive.


Nocturnal positive pressure therapy via CPAP is the therapy of choice in symptomatic OSA. The success of therapy is highly dependent on patient adherence and regular monitoring with sleep studies!



We list the most important complications. The selection is not exhaustive.


  • The mortality rate is higher in patients with severe OSA who do not receive adequate treatment.
  • CPAP ventilation can significantly lower the risk of mortality in OSA.
last updated 11/17/2020
{{uncollapseSections(['C2aqPP', 'B2azPP', 'y2ad4P', 'A2aR4P', 'H3cKPX0', '-2aD4P', 'afaQkP', 'ugcpCb0', 'Xfa9kP', 'cfaaOP', '1fa2OP'])}}